eMedicine Specialties > Ophthalmology > Cornea

Dystrophy, Granular

Author: William Trattler, MD, Miami Center for Excellence in Eye Care; Consulting Staff, Department of Ophthalmology, Miami Baptist Hospital
Coauthor(s): William Lloyd Clark, MD, Consulting Staff, Palmetto Retina; Natalie Afshari, MD, Assistant Professor, Cornea and Refractive Surgery, Department of Ophthalmology, Duke University Eye Center, Duke University Medical Center
Contributor Information and Disclosures

Updated: Mar 15, 2006

Introduction

Background

Granular dystrophy is an autosomal dominant, bilateral, noninflammatory condition that results in deposition of opacities in the cornea by adulthood. It specifically affects the middle portion of the cornea (stroma) and eventually can cause decreased vision and eye discomfort. Severe cases of granular dystrophy can be treated with either excimer laser ablation or by replacing cornea (corneal transplant).

Pathophysiology

The cornea is the clear outer coat of the front of eye. A dystrophy of the cornea is defined as a bilateral noninflammatory clouding of cornea. Corneal dystrophies can be divided into 3 categories based on their location within the cornea, as follows: (1) anterior corneal dystrophies affect the corneal epithelium and may involve the Bowman membrane; (2) stromal corneal dystrophies (which include granular dystrophy) affect the central layer of cornea, the stroma; and (3) posterior corneal dystrophies involve the Descemet membrane and endothelium.

Most corneal dystrophies have an onset prior to age 20 years (exceptions include map-dot-fingerprint dystrophy and Fuchs corneal dystrophy). Most corneal dystrophies are dominantly inherited, exceptions being macular dystrophy, type-3 lattice dystrophy, and the autosomal recessive form of congenital hereditary endothelial dystrophy.

Granular corneal dystrophy types I, II (Avellino dystrophy), have been reported to result from mutations in the BIGH3 gene. Depending on the specific mutation in the beta ig-h3 gene, the phenotypes of corneal dystrophy may differ.

Frequency

United States

Uncommon

International

Uncommon

Mortality/Morbidity

  • Corneal changes generally first become visible during the second decade of life, but vision may not be affected until the fourth to fifth decade of life.
  • Eye pain from recurrent corneal erosions also can occur.

Sex

No sexual predilection has been reported.

Age

Corneal changes usually become visible during the second decade of life, but patients may not be affected until the fourth to fifth decade of life.

Clinical

History

  • Patients may have decreased vision, photosensitivity, and/or eye pain (from recurrent corneal erosions).
  • Because granular dystrophy is autosomal dominant, it is likely that one of the parents will have granular corneal dystrophy as well.

Physical

  • Granular dystrophy is characterized by bilateral formation of discrete, focal, white granular deposits in the anterior stroma of cornea with clear areas between these deposits.
    • The granules are located primarily in the central cornea, with an absence of these deposits in the peripheral cornea.
    • The deposits can resemble crushed breadcrumbs or snowflakes. As patients advance in age, the deposits become larger and increase in number. Eventually, the intervening clear areas develop a mild-to-severe corneal haze.
    • When there are clear spaces between the deposits, the vision generally is not affected severely. However, with time, the clear spaces become involved with opacity. This later onset opacity in the previously clear spaces is usually much more superficial than the longstanding, dense white granules. The vision declines dramatically when the clear spaces opacify.

Causes

Granular dystrophy is an autosomal dominant condition; its genetic defect has been mapped to chromosome 5q.

More on Dystrophy, Granular

Overview: Dystrophy, Granular
Differential Diagnoses & Workup: Dystrophy, Granular
Treatment & Medication: Dystrophy, Granular
Follow-up: Dystrophy, Granular
Multimedia: Dystrophy, Granular
References

References

  1. Albert D, Jakobiec F. Principles and Practice of Ophthalmology. Vol 1. 1994:26-49.

  2. Das S, Langenbucher A, Seitz B. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study. J Refract Surg. Nov-Dec 2005;21(6):727-31. [Medline].

  3. Grunauer-Kloevekorn C, Brautigam S, Wolter-Roessler M. Molecular genetic analysis of the BIGH3 gene in lattice type I (Biber-Haab-Dimmer) and granular type II (Avellino) corneal dystrophy: is indirect mutation analysis for hot spots recommended?. Klin Monatsbl Augenheilkd. Dec 2005;222(12):1017-23. [Medline].

  4. Klintworth GK. Advances in the molecular genetics of corneal dystrophies. Am J Ophthalmol. Dec 1999;128(6):747-54. [Medline].

  5. Krachmer J. Cornea. Vol 2. 1996.

  6. Yamamoto S, Okada M, Tsujikawa M, et al. The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy. Cornea. May 2000;19(3 Suppl):S21-3. [Medline].

Further Reading

Keywords

granular dystrophy, corneal dystrophy, granular corneal dystrophy

Contributor Information and Disclosures

Author

William Trattler, MD, Miami Center for Excellence in Eye Care; Consulting Staff, Department of Ophthalmology, Miami Baptist Hospital
William Trattler, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Coauthor(s)

William Lloyd Clark, MD, Consulting Staff, Palmetto Retina
William Lloyd Clark, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Natalie Afshari, MD, Assistant Professor, Cornea and Refractive Surgery, Department of Ophthalmology, Duke University Eye Center, Duke University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES
Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, Pennsylvania Medical Society, and Philadelphia County Medical Society
Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.